Catalyst Pharmaceuticals
CPRX
#3987
Rank
$2.89 B
Marketcap
$23.53
Share price
1.95%
Change (1 day)
8.43%
Change (1 year)

Catalyst Pharmaceuticals (CPRX) Fails to deliver data

Key failure to deliver metrics for Catalyst Pharmaceuticals:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Catalyst Pharmaceuticals (CPRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Catalyst Pharmaceuticals (CPRX) - since 2013

Volume in USD (price x number of shares), data since 2013

Catalyst Pharmaceuticals (CPRX) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025$0.74 M-79.82%
2024$3.7 M-58.64%
2023$8.95 M52.39%
2022$5.87 M25.46%
2021$4.68 M14.22%
2020$4.1 M-29.1%
2019$5.78 M708.56%
2018$0.71 M65.25%
2017$0.43 M-71.57%
2016$1.52 M37.6%
2015$1.1 M-77.4%
2014$4.89 M-25.66%
2013$6.58 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
BioMarin Pharmaceutical
BMRN
$2.8 M$17.38 M๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
$2.3 M$22.38 M๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$54.31 M$94.31 M๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
N/A$0.01 M๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$24.63 M$0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
$72.42 M$0.44 B๐Ÿ‡บ๐Ÿ‡ธ USA